JP4896827B2 - 角層のＡＧＥｓの鑑別方法 - Google Patents
角層のＡＧＥｓの鑑別方法 Download PDFInfo
- Publication number
- JP4896827B2 JP4896827B2 JP2007168356A JP2007168356A JP4896827B2 JP 4896827 B2 JP4896827 B2 JP 4896827B2 JP 2007168356 A JP2007168356 A JP 2007168356A JP 2007168356 A JP2007168356 A JP 2007168356A JP 4896827 B2 JP4896827 B2 JP 4896827B2
- Authority
- JP
- Japan
- Prior art keywords
- ages
- stratum corneum
- mass
- image
- stained
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 210000000434 stratum corneum Anatomy 0.000 title claims description 54
- 238000000034 method Methods 0.000 claims description 23
- 238000011532 immunohistochemical staining Methods 0.000 claims description 7
- 238000012544 monitoring process Methods 0.000 claims description 5
- 238000004445 quantitative analysis Methods 0.000 claims description 3
- 238000003364 immunohistochemistry Methods 0.000 claims description 2
- 238000011002 quantification Methods 0.000 claims description 2
- 238000012850 discrimination method Methods 0.000 claims 1
- 108010005094 Advanced Glycation End Products Proteins 0.000 description 61
- 239000002537 cosmetic Substances 0.000 description 10
- 238000006243 chemical reaction Methods 0.000 description 9
- 210000001519 tissue Anatomy 0.000 description 9
- 210000000245 forearm Anatomy 0.000 description 8
- 230000032683 aging Effects 0.000 description 7
- 238000012545 processing Methods 0.000 description 6
- 230000001681 protective effect Effects 0.000 description 6
- 108090000623 proteins and genes Proteins 0.000 description 6
- 102000004169 proteins and genes Human genes 0.000 description 6
- 230000000694 effects Effects 0.000 description 5
- 210000002615 epidermis Anatomy 0.000 description 5
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 4
- 239000002390 adhesive tape Substances 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 210000003491 skin Anatomy 0.000 description 4
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- 238000009825 accumulation Methods 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 239000013641 positive control Substances 0.000 description 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- 206010013786 Dry skin Diseases 0.000 description 2
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- 230000004888 barrier function Effects 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 238000004737 colorimetric analysis Methods 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 230000007850 degeneration Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000037336 dry skin Effects 0.000 description 2
- 238000004043 dyeing Methods 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 230000001900 immune effect Effects 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 239000004408 titanium dioxide Substances 0.000 description 2
- 239000008096 xylene Substances 0.000 description 2
- RRUYWEMUWIRRNB-LURJTMIESA-N (2s)-6-amino-2-[carboxy(methyl)amino]hexanoic acid Chemical compound OC(=O)N(C)[C@H](C(O)=O)CCCCN RRUYWEMUWIRRNB-LURJTMIESA-N 0.000 description 1
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 1
- XZIIFPSPUDAGJM-UHFFFAOYSA-N 6-chloro-2-n,2-n-diethylpyrimidine-2,4-diamine Chemical compound CCN(CC)C1=NC(N)=CC(Cl)=N1 XZIIFPSPUDAGJM-UHFFFAOYSA-N 0.000 description 1
- 241000239290 Araneae Species 0.000 description 1
- 229920002160 Celluloid Polymers 0.000 description 1
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 description 1
- 208000007342 Diabetic Nephropathies Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- BIVBRWYINDPWKA-VLQRKCJKSA-L Glycyrrhizinate dipotassium Chemical compound [K+].[K+].O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C([O-])=O)[C@@H]1O[C@H](C([O-])=O)[C@@H](O)[C@H](O)[C@H]1O BIVBRWYINDPWKA-VLQRKCJKSA-L 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- QNHQEUFMIKRNTB-UHFFFAOYSA-N aesculetin Natural products C1CC(=O)OC2=C1C=C(O)C(O)=C2 QNHQEUFMIKRNTB-UHFFFAOYSA-N 0.000 description 1
- GUAFOGOEJLSQBT-UHFFFAOYSA-N aesculetin dimethyl ether Natural products C1=CC(=O)OC2=C1C=C(OC)C(OC)=C2 GUAFOGOEJLSQBT-UHFFFAOYSA-N 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- CEGOLXSVJUTHNZ-UHFFFAOYSA-K aluminium tristearate Chemical compound [Al+3].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CEGOLXSVJUTHNZ-UHFFFAOYSA-K 0.000 description 1
- 229940063655 aluminum stearate Drugs 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 230000003143 atherosclerotic effect Effects 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- JJWKPURADFRFRB-UHFFFAOYSA-N carbonyl sulfide Chemical compound O=C=S JJWKPURADFRFRB-UHFFFAOYSA-N 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 208000020832 chronic kidney disease Diseases 0.000 description 1
- 208000022831 chronic renal failure syndrome Diseases 0.000 description 1
- 238000003759 clinical diagnosis Methods 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 238000010219 correlation analysis Methods 0.000 description 1
- 229940049657 cyclomethicone 5 Drugs 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 208000033679 diabetic kidney disease Diseases 0.000 description 1
- 229940008099 dimethicone Drugs 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 1
- 229940101029 dipotassium glycyrrhizinate Drugs 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- ILEDWLMCKZNDJK-UHFFFAOYSA-N esculetin Chemical compound C1=CC(=O)OC2=C1C=C(O)C(O)=C2 ILEDWLMCKZNDJK-UHFFFAOYSA-N 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000010419 fine particle Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 238000007429 general method Methods 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 108091005996 glycated proteins Proteins 0.000 description 1
- 230000036252 glycation Effects 0.000 description 1
- OIKBVOIOVNEVJR-UHFFFAOYSA-N hexadecyl 6-methylheptanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)CCCCC(C)C OIKBVOIOVNEVJR-UHFFFAOYSA-N 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000028709 inflammatory response Effects 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 230000004807 localization Effects 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 206010033675 panniculitis Diseases 0.000 description 1
- AYEKKSTZQYEZPU-RYUDHWBXSA-N pentosidine Chemical compound OC(=O)[C@@H](N)CCCCN1C=CC=C2N=C(NCCC[C@H](N)C(O)=O)N=C12 AYEKKSTZQYEZPU-RYUDHWBXSA-N 0.000 description 1
- 229960005323 phenoxyethanol Drugs 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000004845 protein aggregation Effects 0.000 description 1
- 230000037070 skin defense Effects 0.000 description 1
- 230000037204 skin physiology Effects 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 229940035044 sorbitan monolaurate Drugs 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 210000004304 subcutaneous tissue Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000009261 transgenic effect Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
Images
Landscapes
- Investigating Or Analysing Biological Materials (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2007168356A JP4896827B2 (ja) | 2007-06-27 | 2007-06-27 | 角層のＡＧＥｓの鑑別方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2007168356A JP4896827B2 (ja) | 2007-06-27 | 2007-06-27 | 角層のＡＧＥｓの鑑別方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2009008460A JP2009008460A (ja) | 2009-01-15 |
| JP2009008460A5 JP2009008460A5 (enExample) | 2010-07-08 |
| JP4896827B2 true JP4896827B2 (ja) | 2012-03-14 |
Family
ID=40323694
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007168356A Active JP4896827B2 (ja) | 2007-06-27 | 2007-06-27 | 角層のＡＧＥｓの鑑別方法 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP4896827B2 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5275898B2 (ja) * | 2009-05-21 | 2013-08-28 | ポーラ化成工業株式会社 | 皮膚状態の評価方法 |
| JP5394501B2 (ja) | 2009-10-02 | 2014-01-22 | シャープ株式会社 | 血管状態モニタリング方法 |
| JP5386634B2 (ja) * | 2010-03-19 | 2014-01-15 | シャープ株式会社 | 測定結果処理装置、測定システム、測定結果処理方法、制御プログラムおよび記録媒体 |
| JP7745647B2 (ja) * | 2021-04-14 | 2025-09-29 | シーメンス・ヘルスケア・ダイアグノスティックス・インコーポレイテッド | 複数の照明源を有する診断機器およびその方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2001122758A (ja) * | 1999-10-22 | 2001-05-08 | Pola Chem Ind Inc | ＡＧＥｓ分解作用を有する老化肌防御、改善化粧料 |
| JP2003261432A (ja) * | 2002-03-07 | 2003-09-16 | Noevir Co Ltd | 皮膚外用剤 |
| JP2003300961A (ja) * | 2002-04-11 | 2003-10-21 | Kumamoto Technology & Industry Foundation | 新規ピリジニウム誘導体およびその利用方法 |
| JP2004340935A (ja) * | 2003-04-21 | 2004-12-02 | Shiseido Co Ltd | 角層における酸化タンパク質の評価方法 |
| JP2007119373A (ja) * | 2005-10-26 | 2007-05-17 | Arkray Inc | メイラード反応生成物分解剤およびそれを用いた飲食品 |
-
2007
- 2007-06-27 JP JP2007168356A patent/JP4896827B2/ja active Active
Also Published As
| Publication number | Publication date |
|---|---|
| JP2009008460A (ja) | 2009-01-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Heiss et al. | Cerebral glucose metabolism as a predictor of rehabilitation after ischemic stroke. | |
| JP6022260B2 (ja) | 皮膚状態の評価方法 | |
| JP4896827B2 (ja) | 角層のＡＧＥｓの鑑別方法 | |
| JP2018099184A (ja) | 菌指標に基づく、肌状態の診断方法及びスクリーニング方法 | |
| JP2020501567A (ja) | 乾燥の徴候を呈している皮膚を診断するための方法 | |
| JP2012098097A (ja) | 蛍光ｘ線分析による生体内金属元素検査方法 | |
| Naveed et al. | Intelligent diabetes detection system based on tongue datasets | |
| CN105699654A (zh) | 皮肤角质层的ngal的表达量的用途 | |
| CN108778124A (zh) | 蛋白质的翻译后修饰的直接红外分析 | |
| JP2009247430A (ja) | 皮膚ａｇｅの非侵襲的鑑別法 | |
| JP5665583B2 (ja) | 肌状態評価方法 | |
| JP7354497B2 (ja) | 非侵襲的なＨｂＡ１ｃ値の推定方法 | |
| CN118141328A (zh) | 一种适用于分化型甲状腺癌患者的术后自助评估系统 | |
| JP5711951B2 (ja) | アディポネクチン及び／又はインスリンの測定方法 | |
| TWI541506B (zh) | 皮膚壓力蓄積的評價方法 | |
| WO2024141907A3 (en) | Methods for diagnosing or monitoring a disease in a subject using spectroscopy | |
| WO2015187874A1 (en) | A method for the detection and/or diagnosis of eating disorders and malnutrition using x-ray diffraction | |
| Naik et al. | Comparison and correlation of glucose levels in serum and saliva of patients with diabetes mellitus | |
| KR102018171B1 (ko) | 타액을 이용한 유방암 감지 키트 및 이를 이용한 유방암 감지 방법 | |
| JP2009153447A (ja) | 敏感肌の診断方法及び敏感肌を予防又は改善する物質のスクリーニング方法 | |
| JP6397733B2 (ja) | ニキビ肌評価方法 | |
| Chien et al. | Clinical implications in the incidence and associated risk factors of gallstone disease among elderly type 2 diabetics in Kinmen, Taiwan | |
| JP2021117164A (ja) | 皮膚炎症状態の評価方法 | |
| Majumder et al. | PS-BPP06-5: PREVALENCE AND DETERMINANTS OF HYPERTENSION AMONG ADULTS: A CROSS SECTIONAL SURVEY OF ONE TRIBAL AREA IN BANGLADESH | |
| JP7256069B2 (ja) | 生体の酸化ストレスの評価方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20100524 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20100524 |
|
| RD03 | Notification of appointment of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7423 Effective date: 20100524 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20110614 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20110615 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20110811 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20111213 |
|
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20111221 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 4896827 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20180106 Year of fee payment: 6 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |